The icp oes spectrometer market has seen considerable growth due to a variety of factors.
• The market size of the ICP-OES spectrometer has witnessed substantial growth in recent times. The market value, which stood at $1.23 billion in 2024, is projected to rise to $1.32 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%.
The upsurge in the historical period was a result of heightened environmental regulations, the expansion of the pharmaceutical sector, an increased requirement for food safety, expansion in scientific research and academic studies, and a growing focus on nanotechnology.
The icp oes spectrometer market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the ICP-OES spectrometer market is predicted to exhibit solid expansion, escalating to a value of $1.71 billion by 2029 at a compound annual growth rate (CAGR) of 6.7%.
This anticipated growth during the forecast span can be credited to the increasing requirements for industrial quality control, broader utility in diagnostic and clinical laboratories, enhanced emphasis on sustainable initiatives, and growing investments and advancements in infrastructure, coupled with superior multi-element analysis capabilities. Essential trends expected during the forecast timeline include prioritization of eco-friendly solutions, an escalation in the adoption of robotics and automation, progress in sensitivity and detection thresholds, improved user-friendly interfaces, and growth in environmental surveillance applications.
The swift expansion of the pharmaceutical and biotechnological sectors is anticipated to fuel the advancement of the ICP-OES spectrometer market in the future. These sectors encompass areas concerned with the conception, progression, manufacture, and launch of drugs and medical products, using chemical and biological operations to treat or manage diseases. The expeditious expansion of these industries is propelled by growing demand for ground-breaking treatments, technological enhancements, and surging global healthcare needs. In these industries, the ICP-OES spectrometer finds application for exact detection and measurement of trace metals and impurities in drugs, raw materials, and biological samples, ensuring alignment with safety and quality norms. For example, in June 2023 as per the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based European commerce association symbolizing the pharmaceutical trades, the total production in the bio-pharmaceutical sphere in Europe was worth $384,200 million (€340,000 million) in 2022, marking an elevation of about 4.95% from $366,267 million (€323,950 million) in 2021. Consequently, the swift expansion of the pharmaceutical and biotechnological sectors is stimulating the progression of the ICP-OES spectrometer market.
The ICP-OES spectrometer market covered in this report is segmented –
1) By Modality: Sequential, Simultaneous
2) By Application: Nanotechnology, Drug Discovery, Environmental Testing, Food And Agriculture, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Other End Users
Subsegments:
1) By Sequential ICP-OES Spectrometer: Single-Element Sequential ICP-OES, Multi-Element Sequential ICP-OES, Portable Sequential ICP-OES
2) By Simultaneous ICP-OES Spectrometer: Benchtop Simultaneous ICP-OES, High-Resolution Simultaneous ICP-OES, Compact Simultaneous ICP-OES
Leading businesses in the ICP-OES spectrometer market are concentrating on the creation of innovative solutions, such as high-resolution spectrometers, to provide extremely exact readings. These high-resolution spectrometers are scientific tools that precisely measure light properties within a certain region of the electromagnetic spectrum. Take for instance SPECTRO Analytical Instruments, a company from Germany that produces elemental analyzers, introduced the SPECTRO ARCOS ICP-OES, a sophisticated elemental analyzer in January 2022. This equipment comes with high-resolution optics and a broad dynamic range, enhancing its sensitivity and precision. It delivers quick and accurate multi-element analysis keeping its durability intact for tough laboratory environments. The SPECTRO ARCOS ICP-OES also comprises easy-to-use software to simplify its operation and data analysis.
Major companies operating in the ICP-OES spectrometer market are:
• Hitachi Ltd.
• Thermo Fisher Scientific Inc.
• DiethelmKellerSiberHegner
• PerkinElmer Inc.
• MKS Instruments Inc.
• Shimadzu Corporation
• Waters Corporation
• Bruker Corporation
• Horiba Ltd.
• Metrohm AG
• Leco Corporation
• PG Instruments Limited
• Analytik Jena AG
• Spectro Analytical Instruments GmbH
• CEM Corporation
• Teledyne Leeman Labs
• Skyray Instrument Inc.
• ELTRA GmbH
• GBC Scientific Equipment
• Drawell
North America was the largest region in the ICP-OES spectrometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ICP-OES spectrometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.